AzTrials
AzTrials

Alcohol UseBAMTECHNCT06994962

Multi-Component Breath Alcohol Intervention Phase 3

A study testing Alcohol-related mobile health technologies, Motivational interview and psychoeducation on blood/breath alcohol concentration and Lower tech facilitation in people with Alcohol Use and Alcohol Drinking, run by Northeastern University at 1 site in United States.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

This is the third stage of a three-stage, NIH-funded study to develop and test a multi-modal intervention concerning blood/breath alcohol concentration for young adults who drink heavily. Read more about this study

Who is it for?
Ages 18 to 25 yearsHealthy volunteers can take part
Conditions the study is for
Alcohol Use, Alcohol Drinking, Drinking Behavior
What is being tested?
Alcohol-related mobile health technologies, Motivational interview and psychoeducation on blood/breath alcohol concentration and Lower tech facilitation
Could I receive a placebo?
No, everyone receives an active treatment
How many people
90 participants
Where
1 siteUnited States
Study dates
1 May 2025to 31 Jan 2027
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 25 years
  • All sexes
  • Healthy volunteers accepted
  • Adult

Who may be able to join

None listed.

Who cannot join

  • No subject may:
  • Have been in inpatient or intensive outpatient treatment within the past 12 months
  • Have used a smartphone application to facilitate moderate drinking more than 1 time within the past 12 months
  • Meet DSM-5 criteria for current substance use disorder with the exception of tobacco use disorder, mild or moderate alcohol use disorder or mild cannabis use disorder.
  • History of alcohol withdrawal or medically-assisted detoxification as individuals with this history will likely be in need of more intensive treatment than is offered in this study.
  • Be psychotic or otherwise severely psychiatrically disabled
  • Report a history of a medical condition that would contraindicate the consumption of alcohol (e.g., liver disease, cardiac abnormality, pancreatitis, diabetes, neurological problems, and gastrointestinal disorders).

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Allie Farone, M.S. contact

a.farone@northeastern.edu

United States1 site, 1 recruiting
  • Northeastern University

    Boston, Massachusetts, 02115-5005

    Jade Martinez, B.S., 617-697-7169, ja.martinez@northeastern.edu

    Allie Farone, M.S., a.farone@northeastern.edu

    Recruiting

Other trials in United States

About this study

Official title: Development and Initial Testing of a Multi-Component Breath Alcohol-Focused Intervention for Young Adults, Stage 3

This is the third stage of a three-stage, NIH-funded study to develop and test a multi-modal intervention concerning blood/breath alcohol concentration for young adults who drink heavily. The multimodal intervention will be made up of brief telehealth counseling and psychoeducation and use of three existing mobile technologies. The brief counseling/psychoeducation and mobile technologies provide personalized feedback regarding blood or breath alcohol content. The long-term goal of use of these mobile technologies will be to facilitate moderate drinking. However, the main goals of the proposed research are to learn more about feasibility of our procedures, perceived value of the technologies and ease of use from the research participants' points of view. In this third stage of the study, the investigators will conduct a randomized controlled trial building on the formative research conducted in Stages 1 and 2.

Being tested
Alcohol-related mobile health technologies, Motivational interview and psychoeducation on blood/breath alcohol concentration, Lower tech facilitation, Higher tech facilitation, Alcohol Education
Medical subject headings
Alcohol Drinking, Drinking Behavior

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Alcohol-related mobile health technologiesDevice

    Also called Smartphone Breathalyzer, BAC Estimator App, Self-Texting App

    Participants will be asked to use the mobile technologies as they choose while drinking for a four-week period.

  • Motivational interview and psychoeducation on blood/breath alcohol concentrationBehavioural

    Also called M.I.

    Brief 25/30-minute motivational interview and psychoeducation on blood/breath alcohol concentration that includes both personalized and standardized information.

  • Lower tech facilitationBehavioural

    Study staff will review instructions for technology use closely with participants and guide them in use of existing phone technologies as reminders for use of the three moderate drinking technologies during drinking situations.

  • Higher tech facilitationBehavioural

    Also called SmartSip

    Participants will use an app developed during the study, SmartSip, that will provide protective behavioral strategies and reminders for use of the three moderate drinking technologies during drinking situations.

  • Alcohol EducationBehavioural

    Brief 25/30-minute psychoeducation on generalized alcohol use providing information about alcohol and its effects, adapted from the National Institute on Alcohol Abuse and Alcoholism (NIAAA) Rethinking Drinking resources

  • Alcohol Education TechnologyDevice

    Participants will be able to prompt text messages which will provide them one-off trivia facts using information provided during the attention control psychoeducation session

Study groups in NCT06994962
Study groupRoleWhat they receive
Moderate drinking technologies with "lower tech" facilitationExperimentalBrief motivational-interviewing-based counseling followed by use of three moderate drinking technologies (breath alcohol device and app, blood alcohol content estimator app and self-texting procedure) with "lower tech" facilitation.
Receives: Device: Alcohol-related mobile health technologies; Behavioral: Motivational interview and psychoeducation on blood/breath alcohol concentration; Behavioral: Lower tech facilitation
Moderate drinking technologies with "higher tech" facilitationExperimentalBrief motivational-interviewing-based counseling followed by use of three moderate drinking technologies (breath alcohol device and app, blood alcohol content estimator app and self-texting procedure) with "higher tech" facilitation
Receives: Device: Alcohol-related mobile health technologies; Behavioral: Motivational interview and psychoeducation on blood/breath alcohol concentration; Behavioral: Higher tech facilitation
Alcohol Education ConditionActive comparatorBrief session administering non-personalized information about alcohol followed by the option to receive educational alcohol-related information via text
Receives: Behavioral: Alcohol Education; Device: Alcohol Education Technology

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Technology utilization

    Percentage of reported drinking days on which one reports that moderate drinking technology use has occurred

    Measured: 4-week field use period

  2. Acceptability

    Score on acceptability subscale of Modified System Usability Scale

    Measured: 4-week field use period

  3. Usability

    Score on acceptability subscale of Modified System Usability Scale

    Measured: 4-week field use period

Secondary outcomes (3)
  1. Drinks per drinking day

    Number of drinks per day during field testing period

    Measured: 4-week field use period

  2. Estimated blood alcohol content

    Average estimated blood alcohol content reached on drinking days

    Measured: 4-week field use period

  3. Negative Consequences

    Score on the Young Adult Alcohol Consequences Questionnaire

    Measured: 4-week field use period

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted29 May 2025
  2. Study start1 May 2025
  3. Primary completion15 Dec 2026 (estimated)
  4. Study completion31 Jan 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Factorial
Masking
None (open label)
Enrolment
90 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06994962
Sponsor's protocol ID
IRB24-12-32
Acronym
BAMTECH
Status last verified
May 2026
First submitted
20 May 2025
Last updated
20 May 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: Study materials and datasets with identifiers removed will be shared with other investigators upon request

Questions about this trial

What is this clinical trial studying?

A study testing Alcohol-related mobile health technologies, Motivational interview and psychoeducation on blood/breath alcohol concentration and Lower tech facilitation in people with Alcohol Use and Alcohol Drinking, run by Northeastern University at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 0 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 20 May 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Jade Martinez, B.S. ((617) 373-5132, ja.martinez@northeastern.edu), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Technology utilization (time frame: 4-week field use period). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 20 May 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in